发明名称 Classes of Compounds that Interact with Integrins
摘要 A method of inhibiting or effecting the activity of an integral receptor which comprises contacting an integrin with a compound of formula I, or a pharmaceutically acceptable salt thereof; General Formula I Wherein the ring may be of any configuration; Z is sulphur, oxygen, CH<SUB>2</SUB>, NH, NR<SUP>A </SUP>or hydrogen, in the case where Z is hydrogen then R<SUP>1 </SUP>is not present, R<SUP>A </SUP>is selected from the set defined for R<SUB>1 </SUB>to R<SUB>5</SUB>, X is oxygen or NR<SUP>A </SUP>providing that at least one X of General Formula I is NR<SUP>A</SUP>, X may also combine independently with one of R<SUB>1 </SUB>to R<SUB>5 </SUB>to form an azide, R 1 to R 5 are independently selected from the group comprising H, -(CO)R<SUB>6 </SUB>or an alkyl, acyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl substituent of 1 to 20 atoms, which is optionally substituted, and can be branched or linear wherein substituents may optionally be further substituted, wherein R<SUB>6 </SUB>is selected from the group comprising an alkyl, acyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl substituent of 1 to 20 atoms, which is optionally substituted, and can be branched or linear wherein substituents may optionally be further substituted, with the proviso that XR<SUB>2 </SUB>or XR<SUB>3 </SUB>or XR<SUB>4 </SUB>or XR<SUB>5 </SUB>is not NH<SUB>2</SUB>, with the further proviso that not more than one of R 2 to R 5 is hydrogen, where the group X is NR<SUP>A </SUP>and R<SUP>A </SUP>is not hydrogen, the groups R<SUP>A </SUP>and the corresponding group R<SUB>2 </SUB>to R<SUB>5 </SUB>may combine to form a cycle.
申请公布号 US2008176936(A1) 申请公布日期 2008.07.24
申请号 US20060813737 申请日期 2006.02.02
申请人 MEUTERMANS WIM;WEST MICHAEL L;THANH LE GIANG;HALLIDAY JUDY;CLARK CHRISTOPHER 发明人 MEUTERMANS WIM;WEST MICHAEL L.;THANH LE GIANG;HALLIDAY JUDY;CLARK CHRISTOPHER
分类号 A61K31/351;A61P3/10;C07D315/00 主分类号 A61K31/351
代理机构 代理人
主权项
地址